Find clinical trials for Multiple Sclerosis (MS) in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near Birmingham, AL, USA:
A safety study of ANK-700 in patients with relapsing remitting multiple sclerosis. The study has two parts:Part A - first in human ...
Phase 1
Cullman, Alabama, United States of America and 14 other locations
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Birmingham, Alabama, United States and 107 other locations
and adolescents 10 to 17 years of age with relapsing forms of multiple sclerosis (MS).Secondary Objective:* To assess the ...
Phase 3
Cullman, Alabama, United States and 54 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Birmingham, Alabama, United States and 33 other locations
A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis...
Phase 3
Birmingham, Alabama, United States and 20 other locations
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...
Phase 1
Birmingham, Alabama, United States and 34 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
Birmingham, Alabama, United States and 60 other locations
Primary Objective:To determine the long-term safety and tolerability of SAR442168 in RMS participantsSecondary Objective:To evaluate efficacy of SAR4...
Phase 2
Cullman, Alabama, United States and 36 other locations
in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...
Phase 3
Birmingham, Alabama, United States and 99 other locations
relapse rate (ARR) in participants with relapsing forms of MSSecondary Objective:To assess efficacy of SAR442168 compared to teriflunomide (...
Phase 3
Birmingham, Alabama, United States and 178 other locations
Clinical trials
Research sites
Resources
Legal